The mortality rate of trachea, bronchus, or lung malignant neoplasms among women in Germany shows a slight decrease. In 2023, the standardized rate stood at 29.2 deaths per 100,000 women. From 2024, forecast data indicates a rate of 29.1, gradually stabilizing at 29.0 in the subsequent years, reflecting a marginal improvement. This trend results in negligible annual changes, implying the disease's impact on mortality remains nearly constant while showing a subtle decline.
Future trends to watch for include advancements in early detection and treatment technologies, increased public health initiatives aimed at reducing smoking prevalence, and evolving environmental and genetic research findings, which can further influence mortality rates in this domain.
